JOURNAL ARTICLE

New Traumatic Stress Disorders Study Results from Kyung Hee University Described (Schizandrin ameliorates post-traumatic stress disorder-like behaviors via 5-HT1A receptor in mice).

  • Published In: Mental Health Weekly Digest, 2025. P. 2468 1 of 2

  • Database: Psychology Source 2 of 2

Abstract

The article focuses on new research investigating the potential of schizandrin, a compound derived from Schisandra chinensis, as a treatment for post-traumatic stress disorder (PTSD). Conducted by researchers at Kyung Hee University in Seoul, South Korea, the study utilized a single prolonged stress mouse model to assess schizandrin's effects on PTSD-like symptoms, including anxiety, depression, and cognitive dysfunction. The findings indicate that schizandrin may alleviate these symptoms by activating the 5-HT receptor and normalizing specific signaling pathways in the brain. The research suggests that schizandrin could be a promising therapeutic candidate for addressing the complex symptoms associated with PTSD. [Extracted from the article]

Additional Information

  • Source:Mental Health Weekly Digest. 2025/10, p2468
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2025
  • ISSN:1543-6616
  • Accession Number:188850941
  • Copyright Statement:Copyright of Mental Health Weekly Digest is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.